Company: IonQ, Inc.
Ticker: IONQ (NYSE)
Date of report: 22 Nov 2025
Stock market information for IonQ Inc (IONQ)
- IonQ Inc is a equity in the USA market.
- The price is 41.71 USD currently with a change of 0.66 USD (0.02%) from the previous close.
- The latest open price was 42.42 USD and the intraday volume is 29301366.
- The intraday high is 42.87 USD and the intraday low is 38.03 USD.
- The latest trade time is Saturday, November 22, 06:29:40 +0530.
- Current share price: ~$41.71
- TTM EPS (GAAP): about –$5.84/share(Yahoo Finance)
- Current P/E: not meaningful / negative (around –7x on simple math)
Section Scores (out of 5, total out of 35)
- Business Quality & TAM: 3/5
- Technology Edge / Moat: 4/5
- Financial Strength (cash & debt): 4/5
- Growth Runway: 5/5
- Management, Incentives & Governance: 2/5
- Valuation vs Fundamentals: 1/5
- Risk/Reward Asymmetry at Today’s Price: 2/5
Total: 21 / 35
2-Year View (my base-case, not gospel)
All of this is very speculative – this is deep tech, pre-profit, with changing accounting noise.
- 2027E revenue (base-case): I’m going to assume something like $250–300M if execution continues and contracts ramp (vs. 2025 guide of $106–110M).(IonQ)
- Likely still loss-making in 2 years under GAAP. Operating expenses and SBC are expanding quickly.(Stock Titan)
My base-case 2-year “fair value” range:
- Expected price (mid): ~$30–35
- Implied 2-yr return from today: roughly –15% to –25% from $41.7
- P/E in 2 years: still negative (so we look at EV/Sales instead, not earnings).
Recommended buy price range (Buffett/Munger style, not momentum-trader style):
If you want this as a long-term, asymmetric bet, not a casino chip, I’d only get seriously interested somewhere around:
Buy zone: roughly $15–22
(that’s closer to ~15–25× a plausible 2027 revenue number rather than ~90–100× 2025 sales today)
At current prices, you’re paying venture-capital prices without having VC control terms.
1️⃣ Founding & Listing History
- Founded: 2015 by Chris Monroe and Jungsang Kim, building on academic trapped-ion research from University of Maryland and Duke.(SEC)
- HQ: College Park, Maryland, USA.(SEC)
- Went public: via SPAC merger with dMY Technology Group III in 2021; listed on NYSE as IONQ.(SEC)
- Age: ~10 years old; public for ~4 years.
- Why SPAC: classic route for pre-revenue, story-driven tech to raise a lot of equity at high implied valuations before revenues are mature. It gave IonQ a giant cash cushion but baked in heavy dilution and warrant overhead.
Score (Founding/Listing history – context only, not in 35-point total):
Not scored, but this is textbook SPAC-era “sell the dream first”.
2️⃣ Plain-Language Company Quality Summary
What they do:
IonQ builds trapped-ion quantum computers and sells access mainly through cloud platforms (AWS Braket, Microsoft Azure Quantum, Google Cloud) and direct contracts, especially with US government and enterprise R&D customers.(IonQ)
Where they are today (numbers):
- 2024 revenue: about $43M, up ~95% YoY.(TradingView)
- 2025 guide: $106–110M revenue (midpoint ~2.5× 2024).(IonQ)
- Q3 2025: $39.9M revenue (+222% YoY) but net loss ~$1.1B mainly due to a huge non-cash warrant liability revaluation plus integration costs for acquisitions.(IonQ)
- Cash & investments: about $1.5B as of 30 Sep 2025, and around $3.5B pro-forma after a $2B equity offering in October.(IonQ)
- Debt: small next to cash – around $20–30M.(Yahoo Finance)
- Shares: ~325M issued and outstanding as of Q3 2025 (vs ~218M end-2024; big dilution already).(Stock Titan)
Quality verdict in plain words:
- Tech & TAM: impressive — they’re one of the leaders in trapped-ion QC, with record fidelities and multi-cloud presence.(Amazon Web Services, Inc.)
- Economics & governance: ugly — extreme stock-based comp, constant equity issuance, giant warrant liabilities, big acquisitions paid mostly in stock, and no line of sight to genuine earnings.(Stock Titan)
From a Buffett/Munger lens:
Wonderful technology, yes. Wonderful business at this price? No.
3️⃣ Business Model & TAM (Score: 3/5)
How IonQ makes money today
- Cloud access / consumption: customers run workloads on IonQ systems on AWS Braket, Azure Quantum, Google Cloud, paying per shot / per job / per time slice.(IonQ)
- Direct & government contracts: large multi-year deals for hardware + services, e.g. the $54.5M US Air Force contract (2024).(IonQ)
- Custom hardware & consulting: specialized quantum systems and joint R&D projects with pharma, materials, logistics, etc.(s28.q4cdn.com)
TAM story
- Management pitches a multi-hundred-billion-plus TAM across optimization, chemistry, materials, security, etc. The real near-term addressable market is tiny: early-stage R&D budgets + government pilots. Quantum is still pre-mainstream.
Why only 3/5?
- Business model is plausible but unproven at scale.
- Revenue is still heavily concentrated in a few large customers and public contracts.(s28.q4cdn.com)
- We don’t yet see “boring, repeatable, sticky” commercial workloads that justify a mature-software type multiple.
4️⃣ Technology Edge / Moat (Score: 4/5)
Tech position
- Uses trapped-ion qubits (as opposed to superconducting, photonic, etc.) with strong coherence and high fidelities; IonQ regularly claims industry-leading fidelities and useful qubit counts.(MLQ)
- Available simultaneously on AWS, Azure, and Google Cloud — currently unique.(HPCwire)
- Acquiring Oxford Ionics (control electronics & trapped-ion IP), Lightsynq (quantum memory), and Capella Space (applications + sensing angle) to build an end-to-end platform.(Reuters)
Competitive field
- Big tech: IBM, Google, Microsoft’s ecosystem.
- Pure plays: Rigetti, D-Wave, Quantinuum (Honeywell/ Cambridge Quantum), etc.(StockLight)
Moat today
- Technical lead + partnerships is genuine, but this is not yet a wide moat in the classical Buffett sense.
- The moat is fragile: if someone else hits bigger breakthroughs or if error-corrected superconducting machines pull ahead, the current advantage can evaporate.
I give 4/5 because within quantum they are positioned like an early Nvidia — but we’re still in the 1980s of that analogy, not 2015.
5️⃣ Financial Strength (Score: 4/5)
Positives:
- Net cash monster:
- Cash, cash equivalents, investments: $1.5B at 30 Sep 2025, $3.5B pro-forma after the $2B equity raise.(IonQ)
- Debt in the tens of millions, negligible vs cash.(Yahoo Finance)
- Assets have jumped with acquisitions (goodwill + intangibles) → total assets about $4.3B vs $2.0B liabilities.(Digrin)
Negatives:
- Huge burn and SBC:
Verdict:
- Balance sheet is very strong today.
- But they’re using shareholders as the funding source instead of customers – which is fine for a startup, not fine if you’re paying a $10B+ equity valuation.
6️⃣ Growth Runway (Score: 5/5)
Recent datapoints:
- Revenues grew nearly 2000% from 2021 to 2024.(IonQ)
- 2024 revenue: $43.1M (+95% YoY).(TradingView)
- 2025 rev guide: $106–110M (+~150% vs 2024).(IonQ)
- Q3 2025: 222% YoY growth to $39.9M.(IonQ)
They’re adding:
- Government contracts (Air Force, etc.),(IonQ)
- Pharma/materials collaborations (AstraZeneca/Nvidia/AWS project),(Barron’s)
- More commercial customers via AWS, Azure, GCP.
So the top line growth is exactly what you’d want from a frontier platform.
5/5 on runway because if quantum delivers, TAM is massive and IonQ is one of the core names.
7️⃣ Management, Incentives & Governance (Score: 2/5)
Positives:
- Leadership has deep tech and capital-markets experience (Peter Chapman previously at Amazon/Flipboard; Niccolo de Masi is a serial tech/space SPAC operator).
- They’ve succeeded in positioning IonQ as the branded quantum story for public markets.
Negatives (the stuff Buffett/Munger would hate):
- SPAC heritage with heavy use of warrants and complex equity structures → we saw a $881.8M non-cash loss from change in warrant liabilities alone.(Stock Titan)
- Aggressive dilution: shares outstanding up from ~218M (Dec 2024) to 325M (Sep 2025), with more coming through acquisitions like Oxford Ionics (all-stock).(Stock Titan)
- Rich stock comp: Q3 2025 SBC nearly $73M vs $39.9M revenue – comp > revenue, which screams “public VC, not compounding machine”.(Quartr)
So I give 2/5: smart people, but playing the Wall Street game hard. Shareholders are the product.
8️⃣ Valuation vs Fundamentals (Score: 1/5)
Let’s do rough, transparent numbers.
Market cap & EV
- Price ≈ $41.7; shares ≈ 325M → market cap around $13.5B (ballpark).(Stock Titan)
- Net cash (pro-forma) ≈ $3.5B → EV ~ $10B.(IonQ)
Revenue
- 2025 guide midpoint ≈ $108M.(IonQ)
So EV/Sales 2025E ≈ 90–100×.
TTM GAAP EPS ≈ –$5.84. At $41.7, that’s P/E ≈ –7.1.(Yahoo Finance)
For comparison:
- Mature high-quality software trades at 8–15× sales when loved.
- Even hot AI infra names rarely sustain >25–30× forward sales once the dust settles.
To justify 90–100× sales, you need decades of flawless execution and the market still paying nosebleed multiples after they’re profitable.
So valuation score: 1/5. This is priced more like a lottery ticket than a business.
9️⃣ Risk/Reward Asymmetry at Today’s Price (Score: 2/5)
Let’s sketch a simple 2-year scenario grid, focusing on EV/Sales:
Base-case (my central guess)
- 2027 revenue ≈ $280M (108M growing ~60–70% CAGR for 2 yrs).
- EV/Sales compresses to ~35× (still very rich).
- EV ≈ 9.8B; assume net cash falls to ~2.5B as they keep burning and doing deals → equity ≈ $12.3B.
- With, say, 360M shares after more stock issuance: price ≈ $34.
From $41.7 → $34 is about –19% over 2 years.
Bull (quantum euphoria persists / more contracts, market still drunk)
- 2027 revenue ≈ $300M.
- EV/Sales still 60× → EV = 18B; cash ~2.5B → equity 20.5B, 360M shares → $57.
- Upside: ~+35% in 2 years.
Bear (hype fades / execution wobbles / more dilution)
- 2027 revenue ≈ $220M.
- EV/Sales falls to 20× → EV = 4.4B; cash ~2B → equity 6.4B, 360M shares → $18.
- Downside: ~–55%.
Given current sentiment and over-valuation, I’d weight the bear/base outcomes more heavily than the bull — hence 2/5 on asymmetry at today’s quote.
🔟 New Frameworks for Thinking About IonQ
A. Quantum “Speculation Triangle”
Three pillars: Tech Validity, Commercial Traction, Capital Discipline.
- Tech Validity: are they actually pushing the frontier?
- IonQ: Strong (4/5) – technical work is real, with world-class fidelity results and leading trapped-ion systems.(MLQ)
- Commercial Traction: are customers paying for real, repeatable value?
- IonQ: Early but promising (3/5) – good growth, but revenues still tiny vs market cap, and concentrated in gov/experiments.(IonQ)
- Capital Discipline: does management protect per-share value?
- IonQ: Weak (1/5) – massive SBC, dilution, warrant noise, large stock-financed deals.
Triangle verdict:
- This is a good “tech + TAM” story wrapped in poor capital discipline. Fine for traders; dangerous for long-term compounding unless your entry price discounts the governance issues.
B. “Buffett Filter for Frontier Tech”
Four classic questions:
- Is it within your circle of competence?
- Quantum physics + error correction + hardware is outside the circle for most investors.
- If you can’t roughly model cash flows, it’s speculation, not investment.
- Does it have a durable competitive advantage?
- Maybe, but the moat is fragile and highly technical. It’s not Coke or See’s Candy; it’s more like owning one promising chip architecture among many.
- Are managers honest and capable and aligned with you?
- Capable, yes. Aligned? Questionable. The compensation/dilution profile suggests they’re optimizing growth and control, not per-share value.
- Are you getting it at a sensible price with a margin of safety?
- At ~90–100× 2025 sales and deeply negative earnings: no.
Buffett-style verdict:
Great science project; at this price, not a value investment.
1️⃣1️⃣ Practical Conclusion – What I’d Do as a “Buffett/Munger” Manager
- If you already hold from much lower levels:
- You’re sitting on a venture-style winner. I’d treat it as house money and size it like a speculative satellite position (low single digits of portfolio). Trim if it gets silly again (like the spike toward $80+).(Capital.com)
- If you own none today:
- At ~$41–42, I would not initiate.
- If you absolutely want quantum exposure, I’d:
- Either wait for a panic / de-rating into the high teens/low 20s, or
- Play it via broad baskets/ETFs where position size and single-name risk is controlled.
- If you insist on a frameworked entry rule:
- Require at least one of:
- Price < ~25× next-year sales and revenue still growing >70%, or
- Clear progress toward positive gross profit after SBC, and/or
- Evidence of stock comp as % of revenue dropping sharply.
- Require at least one of:
At today’s setup, more downside scenarios than upside are already in the price for a long-term owner.
Horizons 
Leave a comment